Inge Jederma PhD Netherlands Cancer Institute / Antoni van Leeuwenhoek
Inge Jederma PhD Netherlands Cancer Institute / Antoni van Leeuwenhoek Head of Translational Cellular Therapy
Since June 2020, Dr. Inge Jedema is Head of Translational Cellular Therapy at the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital in Amsterdam, the Netherlands. In this position she is responsible for the development and implementation of cellular immunotherapy strategies in the field of solid oncology. She studied Biomedical Sciences in Leiden and worked between 1997 and 2020 at the Department of Hematology of the Leiden University Medical Center (LUMC) in the Netherlands. After her PhD research she was leading the Laboratory for Translational Hematology and the diagnostic Laboratory for Specialized Hematology and was responsible for the development and implementation of cellular immunotherapy strategies and the application of ATMPs in clinical trials for patients with hematological malignancies.